California-based cannabis operator Beard Bros has signed a commercial collaboration with vertically integrated UK cannabinoid manufacturer BRITISH CANNABIS to develop and distribute CBD and CBG products across the UK, Europe and North America, in a bi-directional partnership that gives each side a route into the other’s regulated markets.
BRITISH CANNABIS™ Submits Article 4 Application for Non-Novel Status of a Cannabis Ingredient and Receives a Preliminary Green Light.
Canndr® Debuts at The 2023 UK Medicinal Cannabis Awareness Week, the patient-centric platform powered by patients who deserve clarity, information and protection of their rights.
Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased to announce that it has entered into a partnership with BRITISH CANNABIS™ to supply the CBD by BRITISH CANNABIS™ range of pharmacy-grade CBD health supplements to patients via a prescription service through the Group’s online…
Hempura, a leading CBD brand, has recently been acquired by new parent company, BRITISH CANNABIS™.
BRITISH CANNABIS™ is pleased to announce the strategic acquisition and continued operation of PhytoVista Laboratories (a UKAS accredited testing laboratory No. 20213) under one roof., the only cannabinoid specialist lab in the UK to combine Home Office licenses for THC testing, and UKAS accreditation.
New white label CBD food products are back – as the UK’s largest independently owned, producer, and distributor launches a range of CBD products and ingredients that brings innovation back to the sector in a post-novel foods world.
Two companies in the UK CBD and wellness industry team up to drive from the UK to Kyiv, distributing CBD and adaptogenic supplements to the personnel of Non-Government Organisations (NGOs), charities and media teams working on the ground in Ukraine.
Acclaimed Global CBD brand, Elixinol, is making a highly anticipated return to the UK market.
